RxDoctor Payments Data

Jeffrey Deaver, MD

Interventional Pain Medicine · Searcy, ARNPI 1821435439

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Medtronic at 47.9% of the total. Reporting peaked in 2023 at $200 and has fallen 55.9% since, to $88 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in AR, where the typical reported total is $3,706.

$364in general payments, 2019–2025

Across 13 payments — averaging $27.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$174
  • Si-bone, Inc.$52
  • Boston Scientific$44
  • Abbott$23
  • Vertex$22
  • Tersera Therapeutics LLC$21
  • plus $27 from 2 others

What the payments were for

  • Food & beverage$364100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$364 in reported general payments places this provider in the 15th percentile of 29 interventional pain medicine providers in Arkansas.

See all interventional pain medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$300,565
Medicare patients
669
Services billed
4,144

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen594$14,850
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen352$11,050
Gabapentin190$2,800
Tizanidine Hcl125$1,615
Oxycodone Hcl103$1,566
Morphine Sulfate ErMorphine Sulfate68$1,533
Pregabalin63$1,379
Naloxone Hcl19$1,340
Acetaminophen-CodeineAcetaminophen With Codeine29$743
Tramadol Hcl55$503
Cyclobenzaprine Hcl63$493
Morphine Sulfate15$369
Methocarbamol22$283
Hydromorphone Hcl23$247
Baclofen19$232

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Searcy

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →